GlaxoSmithKline (GSK) Reports Q3 Adj-EPS of 28.2P, Sales £6.81B
GlaxoSmithKline (NYSE: GSK) reports ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
